← Back to Search

Behavioral Science Methods for Child Health Education

N/A
Recruiting
Led By Susan Persky, Ph.D.
Research Sponsored by National Human Genome Research Institute (NHGRI)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Participants in the main trial will be healthy adult parents 18 years and older
Participants in the Pilot test will be healthy adult parents 18 years and older
Must not have
Lacking freedom of movement
Low, uncorrected vision and hearing
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at lab visit
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing new behavioral science methods and measures. Eligible participants are parents of children 3-7 years old. There are four tasks involved in the study.

Who is the study for?
This trial is for healthy adult parents, both fathers and mothers, who can read and write in English. They should have children aged between 3-7 years without major allergies or dietary-related health conditions and be able to visit the NIH Clinical Center once.
What is being tested?
The study tests new behavioral science methods by having participants complete tasks like answering questions online about child health, watching a movie scene, reading information on child health topics, and making virtual food choices for their child.
What are the potential side effects?
Since this is a behavioral study involving information provision and emotion induction through various tasks rather than medical interventions, there are no direct physical side effects expected from participation.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a healthy adult parent aged 18 or older.
Select...
I am a healthy adult parent aged 18 or older.
Select...
I am a healthy adult aged 18 to 59.
Select...
I can visit the clinic once.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have difficulty moving around freely.
Select...
I have poor vision and hearing that hasn't been corrected.
Select...
I have epilepsy or a seizure disorder.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at lab visit
This trial's timeline: 3 weeks for screening, Varies for treatment, and at lab visit for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Exhibited emotion, Feeding decisions, self-reported attitudes, beliefs and intentions; perceptual responses

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

7Treatment groups
Experimental Treatment
Group I: 4Experimental Treatment2 Interventions
Loss frame; Fear
Group II: 3bExperimental Treatment1 Intervention
low visual perceptual load
Group III: 3Experimental Treatment2 Interventions
Loss frame; Anger
Group IV: 2bExperimental Treatment1 Intervention
high visual perceptual load
Group V: 2Experimental Treatment2 Interventions
Gain frame; Fear
Group VI: 1bExperimental Treatment1 Intervention
high visual perceptual load high interactive
Group VII: 1Experimental Treatment2 Interventions
Gain frame; Anger

Find a Location

Who is running the clinical trial?

National Human Genome Research Institute (NHGRI)Lead Sponsor
270 Previous Clinical Trials
293,604 Total Patients Enrolled
Susan Persky, Ph.D.Principal InvestigatorNational Human Genome Research Institute (NHGRI)
8 Previous Clinical Trials
4,071 Total Patients Enrolled

Media Library

Provision of information Clinical Trial Eligibility Overview. Trial Name: NCT02622035 — N/A
Healthy Subjects Research Study Groups: 2, 2b, 3, 4, 3b, 1b, 1
Healthy Subjects Clinical Trial 2023: Provision of information Highlights & Side Effects. Trial Name: NCT02622035 — N/A
Provision of information 2023 Treatment Timeline for Medical Study. Trial Name: NCT02622035 — N/A
~73 spots leftby Dec 2025